Bray Capital Advisors’s Avanos Medical AVNS Stock Holding History

Bray Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-92	Closed	-$3K	–	116
2016 Q2	$3K	Buy	+92	New	+$2.82K	﹤0.01%	121
2016 Q1	–	Sell	-92	Closed	-$3K	–	90
2015 Q4	$3K	Sell	92 -812	-90%	-$25.2K	﹤0.01%	126
2015 Q3	$26K	Sell	904 -1,252	-58%	-$43.7K	0.02%	253
2015 Q2	$87K	Buy	2,156 +1,960	+1,000%	+$88K	0.05%	179
2015 Q1	$10K	Buy	+196	New	+$9.08K	0.01%	147

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

Bray Capital Advisors's AVNS Position: Q3 2016 in Review

Bray Capital Advisors sold out of Avanos Medical (AVNS) in Q3 2016, closing a stake of 92 shares — an estimated $3K sold.

Bray Capital Advisors first reported a position in AVNS in Q1 2015 and held it in 5 quarters. The position peaked at $87K in Q2 2015. 359 funds tracked by Wall St. Rank hold AVNS as of Q3 2016.

Bray Capital Advisors reported no remaining Avanos Medical position as of Q3 2016 after selling out during the quarter.
Bray Capital Advisors sold 92 Avanos Medical shares in Q3 2016, an estimated $3K.
Bray Capital Advisors first reported a position in Avanos Medical in Q1 2015 and held it in 5 quarters.
Bray Capital Advisors's Avanos Medical position peaked at $87K in Q2 2015.
359 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2016.

Based on Bray Capital Advisors's 13F filing for Q3 2016, filed 26 Oct 2016.